We are 196,342 members in 81 forums discussing 144,708 topics.

Help with Abbreviations

All TopicsForum: Survey, Interview and Participant Requests: Need your Help! → Topic: Survey for HR+/HER2- metastatic breast cancer patients

Topic: Survey for HR+/HER2- metastatic breast cancer patients

Forum: Survey, Interview and Participant Requests: Need your Help! —

Research proposals and/or requests posted here by members have been reviewed and approved by the Moderator Team, but not associated with Breastcancer.org.

Posted on: Nov 14, 2017 11:14AM

Moderators wrote:

Hello!

Lieberman Research Worldwide (www.LRWonline.com) is conducting a market research study. The findings of this study will help our client to develop communications regarding a specific treatment for HR+/HER2- metastatic breast cancer for patients and their caregivers. Your opinions matter.

The survey is intended for HR+/HER2- breast cancer patients and caregivers. If you qualify and complete this research, metastatic HR+/HER2- BC patients will receive a $100 in appreciation of your time and participation. Other HR+/HER2- BC patients or caregivers will receive $50 honorarium in appreciation of your time and participation. Alternatively, you can choose to donate this honorarium to the American Red Cross Hurricane Harvey Relief or the cancer charity of your choice.

Please be assured that all opinions in the survey remain anonymous and confidential. You will never be personally identified in the research; your responses will only be considered in aggregate. It's also important to note that this research is in no way sales related, and no one will try to sell you anything at any time.

We are excited for you to participate! If you would like to help us with this research, please click on the link below. This link will collect some information first in order to help us determine if you qualify. The survey will take 15 minutes.

https://survey.bz?I.Project=P170749&smp=88&i.user3=6&ID=capiuser

Please note: While this survey is compatible on a desktop or laptop computer, smartphone or tablet, your experience will be best if taking the survey on a desktop or laptop computer.

We look forward to hearing your opinions and appreciate your time and participation.

Thank you!

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Page 1 of 1 (4 results)

Posts 1 - 4 (4 total)

Log in to post a reply

Nov 14, 2017 12:36PM AnimalCrackers wrote:

Is there a way to get a better explanation as to what they mean by "adverse event"?  I couldn't move forward with the survey without knowing what that meant.

Cathy, diagnosed Stage IV de novo June 2014 (age 52). Bone mets at initial diagnosis (2014). Progression to Liver April 2017. Bisphosphonate infusions (Zometa) every 3 months. Clinical Trial 5/18/17 LSZ102 (oral SERD) and Kisqali (Ribociclib). Dx 6/23/2014, IDC, Left, 4cm, Stage IV, metastasized to bone, mets, ER+/PR+, HER2- Hormonal Therapy 6/23/2014 Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone) Hormonal Therapy 1/5/2016 Femara (letrozole) Targeted Therapy 1/5/2016 Ibrance (palbociclib) Dx 4/2017, IDC, metastasized to liver, ER+/PR+, HER2- Hormonal Therapy 5/18/2017 Targeted Therapy 5/18/2017 Kisqali
Log in to post a reply

Nov 14, 2017 01:30PM Moderators wrote:

Let us check!

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 14, 2017 02:05PM Moderators wrote:

AnimalCrackers: They said, "An unintended side effect from a medication."

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 16, 2017 10:54AM DorothyFromKansas wrote:

Takes little time and it is easily (after I disengaged my virus software) completed. The questions got a bit boring but it moves through exercises quickly.

Age 64 at dx, de novo. Mets to chest nodes. Dx 6/29/2017, IBC, Right, Stage IV, metastasized to other, Grade 2, ER+/PR+, HER2- (FISH) Hormonal Therapy 6/29/2017 Arimidex (anastrozole) Targeted Therapy 9/15/2017 Kisqali

Page 1 of 1 (4 results)